BamSEC and AlphaSense Join Forces
Learn More

Unicycive Therapeutics Inc.

NASDAQ: UNCY    
Share price (3/26/25): $0.62    
Market cap (3/26/25): $70.1 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 10-Q 21 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 7 pages First Amendment to Manufacturing and Supply Agreement
12/34/56
EX-10.1
from 10-Q 18 pages Manufacturing and Supply Agreement
12/34/56
EX-10.1
from 8-K 11 pages Exchange Agreement
12/34/56
EX-10.1
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 2 pages Amendment No. 1 to Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 6 pages Personal and Confidential March 3, 2023
12/34/56
EX-10.1
from 8-K 70 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 11 pages License Agreement
12/34/56
EX-10.1
from 8-K 9 pages License Agreement
12/34/56
EX-10.6
from S-1/A 5 pages Service Agreement by and Between the Company and Globavir Biosciences, Inc. Dated July 1, 2017
12/34/56
EX-10.5
from S-1/A 20 pages Exclusive License Agreement by and Between the Company and Sphaera Pharma Pte. Ltd., Dated October 1, 2017
12/34/56
EX-10.4
from S-1/A 52 pages Assignment and Asset Purchase Agreement by and Between Spectrum Pharmaceuticals, Inc. and Unicycive Therapeutics, Inc. Dated as of September 20, 2018
12/34/56
EX-10.2
from S-1/A 31 pages Unicycive Therapeutics, Inc. 2019 Stock Option Plan
12/34/56
EX-10.1
from S-1/A 16 pages Unicycive Therapeutics, Inc. 2018 Equity Incentive Plan
12/34/56
EX-10.10
from S-1 26 pages Master Services Agreement Between Unicycive Therapeutics, INC.AND Ascent Development Services, Inc
12/34/56
EX-10.9
from S-1 2 pages Amendment to Employment Agreement
12/34/56
EX-10.8
from S-1 21 pages Employment Agreement
12/34/56
EX-10.7
from S-1 23 pages Employment Agreement
12/34/56
EX-10.3
from S-1 17 pages Unicycive Therapeutics, Inc. 2021 Omnibus Equity Incentive Plan
12/34/56